Cabergoline (Dostinex) Effect on Weight Ovarian Function
Cabergoline’s common brand name (Dostinex) is a long-acting dopamine receptor agonist, blocks prolactin secretion from the pituitary gland. It is used in Inhibition of physiological lactation…
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Cabergoline’s common brand name (Dostinex) is a long-acting dopamine receptor agonist, blocks prolactin secretion from the pituitary gland. It is used in Inhibition of physiological lactation…
evaluate the effectiveness of Calcium dobesilate (CaD) in comparison to the dopamine agonist cabergoline in preventing OHSS in high-risk patients undergoing assisted reproductive technique cycles. Methods: In this study…
baby. The aim of the study is to conduct a drug use evaluation of cabergoline for lactation inhibition. Method: A retrospective cross-sectional drug use evaluation study was conducted ... Women’s Hospital, Qatar…
Objective: To assess the welfare and efficiency of combined cabergoline and tadalafil in the treatment of patients with psychogenic erectile dysfunction. Patients and methods: From January 2015 to January ... daily…
prolactinoma versus newly diagnosed female patients with idiopathic hyperprolactinemia, and to assess one year-Cabergoline therapy effects on these parameters in both groups by using visceral adiposity index ... Waist…
embryo transfer, daily 5 mg Letrozole and 0.5 mg Cabergoline. One embryo was transferred on day 5 post oocyte retrieval.The patient did not develop any early nor late OHSS while ... succesful ongoing pregnancy was…
accurate spectrophotometric methods are described in the present work for the determination of cabergoline in the pure samples and pharmaceutical formulations. This method I involves quantitative precipitation of drug…
Research question: Does the addition of a gonadotrophin-releasing hormone (GnRH) antagonist to cabergoline treatment during the luteal phase in fresh IVF cycles triggered with a GnRH agonist, and planned ... treatment…
Research question: Does the addition of a gonadotrophin-releasing hormone (GnRH) antagonist to cabergoline treatment during the luteal phase in fresh IVF cycles triggered with a GnRH agonist, and planned ... treatment…
BACKGROUND Cabergoline (CAB) has emerged as an effective and well-tolerated drug for the treatment of hyperprolactinemia. However, the drug was included in the pregnancy risk category
dilatation of the right lateral ventricle. Clinical significant tumour progression occurred under treatment with Cabergoline, leading to hydrocephalus. Patient underwent semi urgent endoscopic transsphenoidal resection…
Fourier Transform Infrared Spectroscopy (FT-IR) and High performance liquid chromatography (HPLC) were adopted. Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used…
Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP) Aisha Elbareg Associate…
ACTH-secreting typical lung carcinoid, successfully and rapidly managed with cabergoline (CAB) and octreotide (OCT) before surgery. She presented with rapidly worsening Cushing’s syndrome and laboratory findings…
prolactin level. An MRI revealed a macroprolactinoma in the pitiutary gland. She was prescribed Cabergoline. However before the macroprolactinoma decreased in size she conceived. The patient was started with Cabergoline…
Background: Dopamine 2 receptor agonists, Bromocriptine and Cabergoline, were originally introduced for prolactinomas and pituitary tumors but have glucose-lowering effects. This paper studied the significance of their…
Patients with DC that used Sandostatin were 80%, being that 55% cabergoline associated, 10% only cabergoline, 10% had no surgery. 30% suspended medications due to successful therapeutics. Conclusion: Our study
peroxisome proliferator-activated gamma (PPARγ) agonists rosiglitazone and pioglitazone, the dopamine D2 agonist cabergoline, and the somatostatin peptidomimetic pasireotide. PPARγ agonists such as rosiglitazone and…
A case of acute pituitary apoplexy. The non-surgical conservative management successfully
have been the cornerstone of prolactinoma therapy, first with bromocriptine and more recently with cabergoline. In up to 85% of patients, cabergoline normalizes prolactin ... cases, it shrinks tumors. Similar to…
group 2 (100%) had headaches. In connection with the above, we recommended the Dostinex (Cabergoline) in dose of 0.25-1 mg for 9 months. In our study, cabergoline normalized ... pituitary. Thus, these studies suggest…
secondary outcome. Five pharmacologic interventions were superior to placebo in decreasing OHSS incidence were cabergoline, metformin, aspirin, intravenous calcium, and hydroxyethyl starch. Glucocorticoid administration…
early timing postpartum (just one day), a dopamine D2 receptor agonist was promptly administrated (cabergoline 1 mg, single dose). Finally, the patient underwent also an endomyocardial biopsy in order ... plasma level…
For authors and organisers
Find the right journal for your paper and submit your manuscript.